European Committee for Treatment and Research in Multiple Sclerosis

Discontinuing Disease-Modifying Therapies in Multiple Sclerosis: Deborah Miller, PhD

November 04, 2021

The staff member at the Mellen Center for Multiple Sclerosis discussed reasons why patients may stop treatment, as well as strategies for maintaining communication with the healthcare team in the event of discontinuation. [WATCH TIME: 5 minutes]

Advances in MS Treatment, ECTRIMS 2021 Takeaways: Lawrence Steinman, MD

October 20, 2021

Discussing this year’s virtual ECTRIMS conference, the Zimmermann Professor of Neurology and Neurological Sciences, and Pediatrics at Stanford University provided his opinion on recent developments in the MS field. [WATCH TIME: 3 minutes]